TL;DR
Get self-care and calm essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A Mayo Clinic study reports that excessive alcohol can move the enzyme VCP away from fat droplets in liver cells, allowing another protein to accumulate and contributing to liver fat buildup. The findings offer a possible explanation for how alcohol contributes to fatty liver disease, but they do not establish a new prevention or treatment, and more research is needed.
Mayo Clinic researchers report that excessive alcohol can disrupt a protein-recycling process in liver cells, offering a possible explanation for how drinking contributes to fat buildup in the liver. The finding identifies changes involving the enzyme VCP and protein HSD17β13, but the report does not say the mechanism has been turned into a treatment or that it accounts for every case of fatty liver disease.
The researchers’ account describes VCP, or valosin-containing protein, as an enzyme that helps clear and recycle damaged proteins in liver cells. Under the process described, alcohol pulls VCP away from fat droplets inside those cells. HSD17β13 then builds up, and the researchers link that accumulation to extra fat collecting in the liver.
Liver cells normally handle fats stored in small structures called lipid droplets; the body can use the stored fat for energy. When too much accumulates, it can contribute to fatty liver disease. Mayo Clinic said researchers used tools to examine protein changes in liver cells and track the movement of VCP and the resulting fat buildup.
The report frames the work as a way to understand early biological steps in alcohol-related liver damage. It does not provide study size, detailed methods, numerical results or evidence that changing VCP or HSD17β13 prevents disease in people. The mechanism is a research finding, not a clinical test or a confirmed treatment.
What the Cell Mechanism Could Explain
The finding may help researchers explain how alcohol contributes to liver fat accumulation at the cellular level. That matters because fatty liver disease can persist and affect liver function; the Mayo Clinic report also says liver damage can raise the risk of cirrhosis, type 2 diabetes and liver cancer. Those complications are risks associated with disease, not outcomes that the study says will happen to every person who drinks.
The work may point to questions for future research, including whether the VCP and HSD17β13 changes can be used to identify or interrupt disease processes. The report does not establish that targeting these proteins would be safe or effective, or that the results change current clinical care. Mayo Clinic’s practical message is that limiting alcohol use is one step that may support liver health; people who drink regularly can discuss their situation with a health care professional.
liver health supplements for fatty liver
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How Alcohol Fits Into Liver Fat
The liver processes substances from food and drink, including alcohol, and also manages fats. Fat stored in liver cells is not by itself the same as a diagnosis of progressive liver disease; the report focuses on how excessive alcohol may contribute to too much fat accumulating and potentially harming the organ.
This account appears as a Mayo Clinic Q&A carried by Seniors Guide and distributed by Tribune Content Agency. It attributes the explanation to Mark McNiven, a Mayo Clinic researcher in biochemistry and molecular biology. The source describes the research in general terms and does not identify a journal article, publication date, participant group or independent replication. It also places the study within Mayo Clinic’s Precure initiative, which aims to develop ways for clinicians to predict and interrupt disease processes before they worsen.
“Alcohol interferes with an enzyme called valosin-containing protein (VCP), which normally helps clean up and recycle damaged proteins in liver cells.”
— Mark McNiven, Ph.D., Mayo Clinic
As an affiliate, we earn on qualifying purchases.
What the Report Does Not Establish
The source does not give the study’s publication details, sample size, exact experimental model, alcohol exposure levels or quantitative results. It is therefore not possible from this report alone to judge the size of the effect, how directly it applies to people, or whether the finding has been independently confirmed.
It also remains unclear whether the VCP and HSD17β13 pathway is a main driver of alcohol-related fatty liver disease or one of several processes involved. The report does not show that the mechanism explains fatty liver disease from causes other than alcohol, nor does it identify a validated way to diagnose or treat the process. Individual risk depends on personal health factors, and the article supplies no safe drinking threshold.
As an affiliate, we earn on qualifying purchases.
Further Research and Clinical Guidance
Mayo Clinic says the work forms part of its Precure initiative, which seeks tools to predict and intercept biological processes before they develop into disease or progress into harder-to-treat conditions. The source does not give a timetable for follow-up studies, clinical trials or a potential intervention. Further published research would be needed to clarify how the cell findings translate to human health and whether they could inform care.
For now, the report advises people who drink regularly to talk with their health care team about alcohol use and liver health. Anyone concerned about their drinking or liver should seek individualized guidance from a qualified health professional; this research report is educational information, not a substitute for medical care.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does alcohol contribute to fatty liver disease in this report?
Mayo Clinic researchers say excessive alcohol can move VCP away from fat droplets in liver cells. They report that HSD17β13 then builds up, a change linked to extra fat collecting in the liver.
Does the research show that everyone who drinks will develop fatty liver disease?
No. The report describes a possible cellular mechanism tied to excessive alcohol exposure. It does not say that everyone who drinks develops fatty liver disease or provide an individual risk estimate.
Is there a treatment based on the VCP finding?
The source does not report a treatment, clinical test or trial based on VCP or HSD17β13. It presents the finding as information that may guide future research.
What should people who drink regularly do?
Mayo Clinic advises discussing alcohol use and liver health with a health care professional. The report says limiting alcohol is one step toward supporting liver health, but it does not give a specific safe limit for each person.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
